News Earnings Abbott India Limited Schedules Board Meeting for February 12, 2026 to Review Q3FY26 Financial ResultsAbbott India Limited Schedules Board Meeting for February 12, 2026 to Review Q3FY26 Financial Results
Abbott India Limited has scheduled its Board of Directors meeting for February 12, 2026, to consider and approve unaudited financial results for the quarter and nine months ended December 31, 2025. The meeting notification was filed under SEBI LODR Regulation 29(1)(a), with the company's trading window closed from January 1, 2026, and set to reopen 48 hours after results declaration in compliance with insider trading regulations.
*this image is generated using AI for illustrative purposes only.
Abbott India Limited has formally notified stock exchanges about its upcoming Board of Directors meeting scheduled for February 12, 2026, to review and approve the company's quarterly financial performance.
Board Meeting Details
The pharmaceutical company filed the intimation on February 4, 2026, under Regulation 29(1)(a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board will convene to consider and approve the unaudited financial results for specific reporting periods.
| Meeting Parameter: | Details |
|---|---|
| Meeting Date: | February 12, 2026 |
| Purpose: | Consider and approve unaudited financial results |
| Reporting Period: | Quarter and nine months ended December 31, 2025 |
| Regulation: | SEBI LODR Regulation 29(1)(a) |
Trading Window Restrictions
In accordance with insider trading regulations, Abbott India has implemented trading window restrictions to ensure compliance with market regulations. The company follows its internal Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders.
The trading window closure details are as follows:
- Closure Date: January 1, 2026
- Reopening: 48 hours after results declaration
- Previous Intimation: December 19, 2025
- Regulatory Framework: SEBI (Prohibition of Insider Trading) Regulations, 2015
Corporate Communication
The official communication was signed by Sangeeta Shetty, Company Secretary (Membership No.: ACS 18865), and digitally authenticated on February 4, 2026. The notification was addressed to BSE Limited and copied to both National Securities Depository Limited and Central Depository Services (India) Limited, ensuring comprehensive market disclosure.
The company maintains its registered office at 3, Corporate Park, Sion Trombay Road, Mumbai, with corporate operations based at Godrej BKC in Bandra-Kurla Complex. Abbott India Limited trades on BSE under scrip code 500488.
Historical Stock Returns for Abbott
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.17% | -1.77% | -3.31% | -19.05% | +4.69% | +88.43% |
